Zai Lab logo

Zai Lab Share Price Today

(NASDAQ: ZLAB)

Zai Lab share price is $35.91 & ₹3,123.06 as on 6 Mar 2025, 2.30 'hrs' IST

$35.91

1.91

(5.62%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Zai Lab share price in Dollar and Rupees. Guide to invest in Zai Lab stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Zai Lab, along with analyst recommendations, forecasts, and comprehensive financials.

Zai Lab share price movements

  • Today's Low: $34.84
    Today's High: $36.02

    Day's Volatility :3.29%

  • 52 Weeks Low: $13.48
    52 Weeks High: $36.60

    52 Weeks Volatility :63.17%

Zai Lab (ZLAB) Returns

PeriodZai Lab LtdSector (Health Care)Index (Russel 2000)
3 Months
21.43%
2.1%
0.0%
6 Months
73.12%
-4.1%
0.0%
1 Year
71.72%
2.2%
0.0%
3 Years
-8.68%
11.8%
-11.6%

Zai Lab (ZLAB) Key Statistics

in dollars & INR

Previous Close
$34.0
Open
$35.07
Today's High
$36.02
Today's Low
$34.835
Market Capitalization
$4.0B
Today's Volume
$408.8K
52 Week High
$36.6
52 Week Low
$13.48
Revenue TTM
$399.0M
EBITDA
$-270.3M
Earnings Per Share (EPS)
$-2.6
Profit Margin
-64.44%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-31.41%

How to invest in Zai Lab Stock (ZLAB) from India?

It is very easy for Indian residents to invest directly in Zai Lab from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zai Lab stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zai Lab or ZLAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zai Lab or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zai Lab shares which would translate to 0.024 fractional shares of Zai Lab as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zai Lab, in just a few clicks!

Returns in Zai Lab (ZLAB) for Indian investors in Rupees

The Zai Lab stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Zai Lab investment value today

Current value as on today

₹1,86,326

Returns

₹86,326

(+86.33%)

Returns from Zai Lab Stock

₹81,364 (+81.36%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Zai Lab (ZLAB)

79%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Zai Lab Stock from India on INDmoney has increased by 79% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Zai Lab

  • Wellington Management Company LLP

    6.15%

  • HHG PLC

    6.07%

  • Capital World Investors

    5.94%

  • FMR Inc

    5.06%

  • Morgan Stanley - Brokerage Accounts

    2.92%

  • RTW INVESTMENTS, LLC

    2.32%

Analyst Recommendation on Zai Lab

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Zai Lab(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Zai Lab Stock (ZLAB)

What analysts predicted

Upside of 50.53%

Target:

$54.06

Current:

$35.91

Insights on Zai Lab Stock (Ticker Symbol: ZLAB)

  • Price Movement

    In the last 1 month, ZLAB stock has moved up by 26.3%
  • Increasing Revenue

    Revenue is up for the last 5 quarters, 65.83M → 109.07M (in $), with an average increase of 11.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -41.67M → -81.68M (in $), with an average decrease of 96.0% per quarter
  • ZLAB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 63.7%

Zai Lab Technicals Summary

Sell

Neutral

Buy

Zai Lab is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Zai Lab (ZLAB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zai Lab Ltd logo
24.18%
73.12%
71.72%
-8.68%
-35.1%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zai Lab Ltd logo
NA
NA
NA
-1.62
-0.31
-0.16
NA
7.8
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zai Lab Ltd logo
Buy
$4.0B
-35.1%
NA
-64.44%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Zai Lab

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
Organization
Zai Lab
Employees
1869
CEO
Dr. Ying Du Ph.D.
Industry
Health Technology

Management People of Zai Lab

NameTitle
Dr. Ying Du Ph.D.
Founder, Chairperson & CEO
Mr. Joshua L. Smiley
President & COO
Dr. Rafael G. Amado M.D.
President and Head of Global Research & Development
Dr. Yajing Chen Ph.D.
Chief Financial Officer
Dr. Peter Huang Ph.D.
Chief Scientific Officer
Ms. Christine Chiou
Senior VP & Head of Investor Relations
Mr. Frazor Titus Edmondson III, J.D.
Chief Legal Officer & Joint Corporate Secretary
Dr. Jonathan J. Wang MBA, Ph.D.
Chief Business Officer
Dr. James Yan DABT, M.D., Ph.D.
Chief Operating Officer of R&D
Mr. Tong Zhu
Chief Commercial Officer of Greater China

Important FAQs about investing in ZLAB Stock from India :

What is Zai Lab share price today?

Zai Lab share price today stands at $35.91, Open: $35.07 ; Previous Close: $34.00 ; High: $36.02 ; Low: $34.84 ; 52 Week High: $36.60 ; 52 Week Low: $13.48.

The stock opens at $35.07, after a previous close of $34.00. The stock reached a daily high of $36.02 and a low of $34.84, with a 52-week high of $36.60 and a 52-week low of $13.48.

Can Indians buy Zai Lab shares?

Yes, Indians can invest in the Zai Lab (ZLAB) from India.

With INDmoney, you can buy Zai Lab at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Zai Lab at zero transaction cost.

How can I buy Zai Lab shares from India?

It is very easy to buy Zai Lab from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zai Lab (ZLAB) be purchased?

Yes, you can buy fractional shares of Zai Lab with INDmoney app.

What are the documents required to start investing in Zai Lab stocks?

To start investing in Zai Lab, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Zai Lab Stock (ZLAB)?

Today’s highest price of Zai Lab (ZLAB) is $36.02.

Today’s lowest price of Zai Lab (ZLAB) is $34.84.

What is today's market capitalisation of Zai Lab?

Today's market capitalisation of Zai Lab ZLAB is 4.0B

What is the 52 Week High and Low Range of Zai Lab Stock (ZLAB)?

  • 52 Week High

    $36.60

  • 52 Week Low

    $13.48

What are the historical returns of Zai Lab (ZLAB)?

  • 1 Month Returns

    24.18%

  • 3 Months Returns

    73.12%

  • 1 Year Returns

    71.72%

  • 5 Years Returns

    -35.1%

Who is the Chief Executive Officer (CEO) of Zai Lab ?

Dr. Ying Du Ph.D. is the current Chief Executive Officer (CEO) of Zai Lab.